National Stockpiles Affect Medicine Access in Some EU Countries
Medicines for Europe shared on LinkedIn:
”Fragmented national stockpiling policies are making essential medicines harder to access in some EU countries, extending shortages and exposing our internal market.
In Germany, a 6-month stockpile equals almost 2 years’ supply for the Netherlands. Uncoordinated stockpiling risks destabilizing smaller markets and reducing treatment availability in other regions.
For example, 70% of companies have observed longer stockout periods and reduced availability of medicines in smaller markets, due to stockpiling requirements.
We need a unified approach to ensure timely and equal access for patients, as well as robust supply chains based on proportionate measures and EU solidarity.
Check out our report to learn more.”
Find more posts on Hemostasis Today.
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy